Showing results (81-90 of 122) with videos related to
Sort By:
Pageof 13
Current Research in Translational Medicine|April 20, 2025
Perspectives on the use and availability of chimeric antigen receptor T cells (CAR-T) and cell therapies: A worldwide cross-sectional survey by the worldwide network for blood and marrow transplantation (WBMT)Eddie Hp Tan, Mahmoud Aljurf, Fazal Hussain, et al.Leukemia|December 22, 2022
Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity mattersPeter-Martin Bruch, Sascha Dietrich, Herve Finel, et al.Frontiers in Immunology|August 15, 2020
Association of Country-Specific Socioeconomic Factors With Survival of Patients Who Experience Severe Classic Acute Graft-vs.-Host Disease After Allogeneic Hematopoietic Cell Transplantation. An Analysis From the Transplant Complications Working Party of the EBMTAndrzej Frankiewicz, Christophe Peczynski, Sebastian Giebel, et al.The Lancet. Haematology|January 6, 2024
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Mahmoud Aljurf, et al.Hematology/Oncology and Stem Cell Therapy|August 27, 2019
Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyondMarcelo C Pasquini, Alok Srivastava, Syed Osman Ahmed, et al.The Lancet. Haematology|March 5, 2025
Ask, do not tell: consulting a patient advisory board to understand unmet needs of patients with GVHD in EuropeHélène Schoemans, Elke Stienissen, Kathy Goris, et al.British Journal of Haematology|March 2, 2019
Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemiaNicolaus Kröger, Diderik-Jan Eikema, Linda Köster, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2023
Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE StudyDavid Bernard Miklos, Mohammad Abu Zaid, Julian P Cooney, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 10, 2019
Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and BeyondMarcelo C Pasquini, Alok Srivastava, Syed Osman Ahmed, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 27, 2020
The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease StudyAndrew J Cowan, Helen Baldomero, Yoshiko Atsuta, et al.Pageof 13